PMC:4307366 / 338-814 JSONTXT

{"project":"NEUROSES","denotations":[{"id":"T20","span":{"begin":204,"end":215},"obj":"CHEBI_8871"},{"id":"T27","span":{"begin":219,"end":228},"obj":"CHEBI_3223"},{"id":"T31","span":{"begin":140,"end":147},"obj":"PATO_0001786"},{"id":"T32","span":{"begin":294,"end":298},"obj":"CHEBI_23888"},{"id":"T33","span":{"begin":400,"end":404},"obj":"CHEBI_23888"}],"text":"Materials \u0026 Methods\nIn this crossover clinical trial study, patients with severe behavior disorders after medical examination were randomly divided into two groups of two 8-week crossover treatments with risperidone or buspirone. Patient behavioral disorders before and after treatment by each drug was rated by parents on the Nisonger Child Behavior Rating Form (NCBRF), and after treatment by each drug, were assessed by a physician through clinical global impression (CGI)."}